Literature DB >> 10604326

Longitudinal changes in peak urinary flow rates in a community based cohort.

R O Roberts1, S J Jacobsen, D J Jacobson, T Rhodes, C J Girman, M M Lieber.   

Abstract

PURPOSE: We describe longitudinal changes in peak urinary flow rates in community dwelling men in Olmsted County, Minnesota.
MATERIALS AND METHODS: A cohort of 2,115 men 40 years old or older was randomly selected from the Olmsted County, Minnesota population. Peak urinary flow rates and the American Urological Association symptom index were assessed in all men at baseline and biennially, and in a 25% random subsample prostate volume was determined by transrectal ultrasonography. The annualized percentage change in peak urinary flow rate (slope) was assessed for 492 men in the subsample during 6 years of followup.
RESULTS: Median peak urinary flow rate slope was -2.1% per year (25th percentile -4.0, 75th percentile -0.6). Peak urinary flow rate declined more rapidly with decreasing baseline rate, and increasing baseline age, prostate volume and symptom severity (all p = 0.001). When the variables were simultaneously adjusted for each other, a rapid decline (negative slope 4.5% or greater per year) was more likely in men 70 years old or older (odds ratio 46.4, 95% confidence intervals 16.8, 127.7) and those with a rate less than 10 ml. per second (42.0, 14.1, 125.3) at baseline compared to those 40 to 49 years old and those with a rate of 15 ml. or greater, respectively. Prostate volume and symptom severity were not statistically significant predictors of a rapid decline in peak urinary flow rate when variables were considered simultaneously.
CONCLUSIONS: Despite variability in measurement of peak urinary flow rate, a consistent decline was observed when measured longitudinally in a community based cohort. Furthermore, this decline was associated with impairments in other physiological and anatomical measures of lower urinary tract function in an unselected cohort of men.

Entities:  

Mesh:

Year:  2000        PMID: 10604326

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  26 in total

Review 1.  HoLEP has come of age.

Authors:  Michael W Vincent; Peter J Gilling
Journal:  World J Urol       Date:  2014-11-22       Impact factor: 4.226

2.  Early sequential changes in bladder function after partial bladder outlet obstruction in awake sprague-dawley rats: focus on the decompensated bladder.

Authors:  Yong-Jin Kang; Long-Hu Jin; Chang-Shin Park; Hwa-Yeon Shin; Sang-Min Yoon; Tack Lee
Journal:  Korean J Urol       Date:  2011-12-20

3.  Age-related changes in prostate zonal volumes as measured by high-resolution magnetic resonance imaging (MRI): a cross-sectional study in over 500 patients.

Authors:  Baris Turkbey; Robert Huang; Srinivas Vourganti; Hari Trivedi; Marcelino Bernardo; Pingkun Yan; Compton Benjamin; Peter A Pinto; Peter L Choyke
Journal:  BJU Int       Date:  2012-09-14       Impact factor: 5.588

4.  Associations between longitudinal changes in serum estrogen, testosterone, and bioavailable testosterone and changes in benign urologic outcomes.

Authors:  Jennifer L St Sauver; Debra J Jacobson; Michaela E McGree; Cynthia J Girman; George G Klee; Michael M Lieber; Steven J Jacobsen
Journal:  Am J Epidemiol       Date:  2011-03-02       Impact factor: 4.897

5.  Age-stratified normal values for prostate volume, PSA, maximum urinary flow rate, IPSS, and other LUTS/BPH indicators in the German male community-dwelling population aged 50 years or older.

Authors:  Richard Berges; Matthias Oelke
Journal:  World J Urol       Date:  2011-01-08       Impact factor: 4.226

Review 6.  Early treatment of benign prostatic hyperplasia: implications for reducing the risk of permanent bladder damage.

Authors:  Andrea Tubaro; Simon Carter; Alberto Trucchi; Giorgio Punzo; Stefano Petta; Lucio Miano
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

7.  Intravesical prostatic protrusion in men in Olmsted County, Minnesota.

Authors:  Michael M Lieber; Debra J Jacobson; Michaela E McGree; Jennifer L St Sauver; Cynthia J Girman; Steven J Jacobsen
Journal:  J Urol       Date:  2009-10-17       Impact factor: 7.450

8.  Prospective factor analysis of alpha blocker monotherapy failure in benign prostatic hyperplasia.

Authors:  Kyoung Pyo Hong; Young Joon Byun; Hana Yoon; Young Yo Park; Woo Sik Chung
Journal:  Korean J Urol       Date:  2010-07-20

9.  Associations between C-reactive protein and benign prostatic hyperplasia/lower urinary tract symptom outcomes in a population-based cohort.

Authors:  Jennifer L St Sauver; Aruna V Sarma; Debra J Jacobson; Michaela E McGree; Michael M Lieber; Cynthia J Girman; Ajay Nehra; Steven J Jacobsen
Journal:  Am J Epidemiol       Date:  2009-04-24       Impact factor: 4.897

10.  Patterns in the diagnosis and management of benign prostatic hyperplasia in a country that does not have country-specific clinical practice guidelines.

Authors:  Jae-Seung Paick; Soo Woong Kim; Ja Hyeon Ku
Journal:  Yonsei Med J       Date:  2007-04-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.